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Metabolic footprinting has become a valuable analytical approach for the characterization
of phenotypes and the distinction of speciﬁc metabolic states resulting from environmental and/or
genetic alterations. The metabolic impact of heterologous protein production in Escherichia coli cells
is of particular interest, since there are numerous cellular stresses triggered during this process that
limit the overall productivity, e.g. the stringent response. Because the knowledge on the metabolic
responses in recombinant bioprocesses is still scarce, metabolic footprinting can provide relevant
information on the intrinsic metabolic adjustments. Thus, the metabolic footprints generated by
E. coli W3110 and the DrelA mutant strain during recombinant fed-batch fermentations at diﬀerent
experimental conditions were measured and interpreted. The IPTG-induction of the heterologous
protein expression resulted in the rapid accumulation of inhibitors of the glyoxylate shunt in the
culture broth, suggesting the clearance of this anaplerotic route to replenish the TCA intermediaries
withdrawn for the additional formation of the heterologous protein. Nutritional shifts were also
critical in the recombinant cellular metabolism, indicating that cells employ diverse strategies to
counteract imbalances in the cellular metabolism, including the secretion of certain metabolites that
are, most likely, used as a metabolic relief to survival processes.
Introduction
The optimization of bioprocesses using recombinant micro-
organisms is still restrained by the lack of information available
on the metabolic responses induced by various stress conditions.1
Signiﬁcant knowledge could be gained from a comprehensive
analysis of the metabolic footprint (i.e. extracellular metabolite
proﬁling) by inspecting key metabolic changes and understanding
their relation with environmental conditions.2–8
Some work has been published addressing various meta-
bolic responses during the production of heterologous proteins
in Escherichia coli.9 Experimental studies showed that the
host cell metabolism undergoes a severe metabolic burden,
resulting in rapid exhaustion of essential precursors and
cellular energy.10 Typically, strong expression systems are
employed to assure the production of large amounts of
heterologous proteins by the host, which uses a large quantity
of metabolic and energy resources in order to maintain and
express the foreign DNA.11
Heterologous protein production is also believed to diminish
ﬂow in the TCA cycle through the withdrawal of intermediates
that serve as precursors for amino acid biosynthesis.12 More-
over, the diﬀerence usually observed in amino acid composition
of foreign proteins and the average composition of the host
proteins contributes to this metabolic imbalance.13–16
Stringent response has been associated with the stress
phenomenon caused by the depletion of certain metabolic
resources, namely amino acids.17 The increased level of free
tRNA molecules, due to the lack of amino acids, triggers this
stress response that is characterized by the arrest of the
ribosomal translation process and the rapid RelA-mediated
accumulation of ppGpp.18 This nucleotide has been found19–21
to bind directly to the RNA polymerase, adjusting the
transcriptional activity from the expression of genes required
for rapid growth, to stress-related genes and amino acid
biosynthetic operons.22–25 The regulatory mechanisms of this
ppGpp-induced stress response are known in some detail,26–28
but the impact of this response on the cellular metabolism has
been less studied. Knowledge on how these responses take
place and how to dodge them is of great importance, since
E. coli has become one of the most used microbial systems to
produce heterologous proteins.
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Here, we aimed at investigating the physiological andmetabolic
changes in E. coli cultures during the production of heterologous
proteins by performing a metabolic footprinting analysis.
Furthermore, the focus of the study was not only to evaluate
the changes of the extracellular metabolite pools during hetero-
logous protein production, but also to assess the eﬀect of
removing a gene closely related to the initiation of the stringent
response (relA) on the cellular behaviour. Thus, the W3110 and
the isogenic mutant (DrelA) E. coli strains were grown and
induced to produce a heterologous protein (AcGFP1) at diﬀerent
nutritional conditions in a controlled fed-batch mode.
Results
Fed-batch fermentations of W3110 and DrelA E. coli cells
To elucidate the physiological responses of theW3110 and DrelA
mutant E. coli strains during recombinant fed-batch fermenta-
tion, cells were grown aerobically with a closed-loop feeding
control to maintain a quasi-steady state growth. Two fed-batch
cultures, one with each strain, were started with a low speciﬁc
growth rate (between 0.09 and 0.16 h1) and growth charac-
teristics were determined prior and after IPTG induction
(phases A and B, respectively). Then, the glucose feeding rate
was increased to maintain the speciﬁc growth rate around 0.2 h1
(phase C) to evaluate the impact of nutritional upshift on the
E. coli cultures during heterologous protein production. Nutrient
limitation by ceasing the glucose feeding (phase D) was ﬁnally
examined in these E. coli cultures until growth is arrested.
In Fig. 1, biomass, glucose, acetate and AcGFP1 concentra-
tions are depicted for each fed-batch culture. Table 1 shows the
growth parameters determined at each experimental condition.
As demonstrated, prior to IPTG induction the speciﬁc growth
rates were similar for both strains (around 0.16 h1), but after
IPTG induction the growth of the wild-type strain was signiﬁ-
cantly reduced (0.092 h1) while the DrelAmutant had a speciﬁc
growth rate of 0.13 h1. In contrast, the AcGFP1 production
increased after IPTG induction to a maximum of around
7  103 g g1 DW h1 for both cultures. Upon the nutritional
upshift (phase C), both strains increased their growth rates and
the AcGFP1 production rates. The maximumAcGFP1 produc-
tion was determined to be close to 20  103 g g1 DW h1 in
both cultures. At these conditions acetate accumulation was
detected in both cultures at rates below 90 103 g g1 DW h1.
When the glucose feeding was stopped (phase D) acetate
was consumed and growth was arrested. However, AcGFP1
production continued until the carbon sources (i.e. glucose
and acetate) were completely depleted from the medium.
Fig. 1 (a) Growth curves for the W3110 [pTRC-His-AcGFP1] and the isogenic derivative DrelA251::kan E. coli strains cultured in fed-batch
fermentations with closed-loop feeding control. (b) Sampling scheme for GC-MS analysis. Samples were harvested at regular intervals during the
four fermentation phases: A—prior to induction; B—after IPTG induction; C—after growth upshift; and D—after nutrient downshift. The ﬁrst
sample (A-1) was taken when the biomass concentration was around 0.6 g kg1 (corresponding to sampling point T0) and then samples were
collected every 40–50 minutes (corresponding to sampling points T1 to T17). Time series were similarly deﬁned in both fed-batch fermentations.
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Metabolic footprint analysis
Gas chromatography–mass spectrometry (GC-MS) has been
widely used in the analysis of a large number of compounds
such as amino acids, sugars, and organic acids. In this work, a
GC-MS-based analytical platform established by Villas-Boˆas’
group29 (detailed in the Experimental section) was used to
detect amino and nonamino organic acids secreted by E. coli
cells during fed-batch cultures. Samples taken for metabolic
footprinting were harvested at regular time intervals and the
amount of samples taken in each growth phase was consistent
between fed-batch fermentations (Fig. 1). Time series data
were further examined to address any changes in the metabolic
footprints resulting from the alteration of culture conditions
and to verify if the relA gene mutation could actually inﬂuence
the metabolic behaviour of this recombinant E. coli strain.
A wide variety of metabolites was detected in the extra-
cellular medium, including fatty, amino and organic acids
(see Fig. 2 and ESI 1w). These metabolites could either
accumulate in the extracellular medium via secretion/excretion
by cells or by means of the accumulation of components from
the feeding media that were not completely exhausted, which is
only the case of isoleucine (see media composition in the
Materials and Methods section). Some of these metabolites
were uniquely detected in the fed-batch fermentation with
E. coli DrelA (e.g., phenylalanine (phe), acetyl-L-glutamate
(acglu), octadecenoate (ocdcea) and tetradecanoate (ttdca)),
which indicates that metabolic diﬀerences between the two
fed-batch experiments might exist. These metabolites were
found to be mainly involved in the central carbon metabolism,
including the tricarboxylic acid cycle (TCA cycle), the bio-
synthesis of amino and fatty acids as well as other energy
generating metabolic reactions. However, we detected metabolites
such as itaconate, malonate, 2-phenylglycine and benzoate
that could not be linked directly to any known metabolic
pathway of E. coli, according to public databases (such as
KEGG30 and EcoCyc)31 and genome-scale metabolic models
(e.g. iAF1260 model ofE. coliK12).32 However, these metabolites
are known to participate in metabolic reactions of other
organisms.33,34 Therefore, resemblances between enzyme-
coding genes from other organisms that produce these meta-
bolites with the E. coli genome were investigated, but it was
not possible to establish with conﬁdence their participation as
reactants/products in E. coli reactions. Yet, itaconate and
malonate have been described as in vitro inhibitors of a key
enzyme of the E. coli anaplerotic metabolism, i.e., isocitrate
lyase, the ﬁrst enzyme of the glyoxylate cycle,35 indicating that
at least these metabolites are likely to be produced during
E. coli growth. Further information is available in the ESI 1.w
Principal components analysis (PCA) was initially performed
to investigate whether the samples from diﬀerent fermentation
phases could be distinguished based on their metabolic
footprints proﬁles and to determine the signiﬁcant metabolic
diﬀerences between the W3110 and DrelA mutant E. coli
strains (Fig. 3).
To investigate these diﬀerences, metabolic footprint data
from the two E. coli cultures were compared (Table 2). For
each metabolite, the Pearson correlation coeﬃcient (r) was
calculated for the average Z-score values in order to evaluate
the similarities between metabolite proﬁles produced in each
culture and to ﬁnd which metabolites are likely to explain the
diﬀerences depicted in Fig. 3. As shown in Table 2, the majority
of metabolites presented Pearson’s correlation coeﬃcients
that were found signiﬁcant after performing Student’s t test
(p-values higher than 0.05). However, metabolites like
2-phenylglycine (2paac), fumarate (fum), malate (mal) and
octadecanoate (ocdca) showed relatively lower coeﬃcients,
indicating that their proﬁles were distinct between the two
E. coli cultures. Although there are few metabolites with
uncorrelated proﬁles, diﬀerences in sample projections along
PCs, in particular samples from phase D, might be associated
with the presence of some metabolites that were only detected in
one of the fed-batch cultures. For example, the metabolites
isoleucine (ile), phenylalanine (phe), acetyl-L-glutamate (acglu),
octadecenoate (ocdcea) and tetradecanoate (ttdca) were only
detected in the fed-batch culture with the DrelA mutant strain
during the last fermentation phase (i.e. phase D), indicating that
cells were likely at diﬀerent metabolic states and metabolic
activities carried out by the two E. coli strains were distinct.
Although the diﬀerences found between the DrelA mutant
and W3110 strain may result from changes associated with the
genetic perturbation, we cannot ignore the intrinsic metabolic
variability that is common to most systems. As reported
previously,36 ﬂuctuations may arise because organisms are
never in the same exact metabolic stage, even when growing
Table 1 Growth parameters of the fed-batch cultures of the W3110 and DrelA E. coli strains. 95% conﬁdence intervals are indicated after the
symbol 
Strain Phases
Speciﬁc growth
rate set point/h1
Expected biomass
yield/gDW g
1
substrate Speciﬁc rates/g g
1 DW h1
Biomass yield/gDW g
1
substrate
m YX/S m qAcGFP1 (  103) qGluc qAc YX/S
W3110 A 0.1 0.35 0.16  0.020 0.60  0.12 0.30  0.067 — 0.59  0.038
B 0.1 0.35 0.092  0.023 6.8  4.5 0.29  0.052 — 0.36  0.065
C 0.2 0.2 0.17  0.023 19  6.0 0.64  0.11 0.089  0.0074 0.26  0.068
D — — — 5.3  5.8 0.24  0.043 0.49  0.27 0.31  0.069a
DrelA A 0.1 0.35 0.16  0.019 0.60  0.45 0.21  0.016 — 0.62  0.059
B 0.1 0.35 0.13  0.026 6.9  3.8 0.25  0.036 — 0.48  0.022
C 0.2 0.2 0.20  0.030 17  1.8 0.56  0.089 0.084  0.0072 0.36  0.010
D — — — 14  2.1 0.47  0.14 0.92  0.23 0.04  0.049a
Speciﬁc growth rate (m), AcGFP1 production (qAcGFP1), glucose uptake (qGluc) and acetate formation (qAc) speciﬁc rates.
a These parameters were
calculated for biomass growth under acetate consumption.
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in the same conditions, and small diﬀerences in enzyme con-
centrations may also aﬀect metabolite concentrations. Thus,
to better understand these diﬀerences, the metabolic footprints
from each culture were further examined independently by
clustering analyses (Fig. 4 and 5).
Hierarchical clustering analysis (HCA) was used to evaluate
the metabolic footprints produced by cells during the fed-batch
fermentations. As shown in Fig. 4a, for the W3310 culture,
samples from the same fermentation phase, including sample
replicates, were clustered together, which indicates that those
samples have similar metabolite proﬁles. Metabolite clusters
evidenced the association between metabolite patterns generated
along the fermentation process. The starting hypothesis is that
metabolites that show a similar variation are related, a relation
that conveys information about their proximity or func-
tion within the metabolic map. For example, the metabolite
proﬁles of citrate (cit), aspartate (asp), 4-hydroxybenzoate
(4hbz), cis-aconitate (acon-C) and itaconate (itcon) were
clustered at these experimental conditions, meaning that in
the W3110 E. coli culture these metabolites follow a close
pattern.
Similarly, samples from the recombinant DrelAmutant were
grouped into four major clusters (Fig. 5a). However, in this
case, samples were clustered diﬀerently. Samples from phase A
clustered together, but samples taken immediately after IPTG
induction (triplicate samples from B-1 to B-3) clustered together
with samples from phase A. The following samples from phase
B: i.e. samples B-4 and B-5, including replicates, clustered
Fig. 2 Schematic diagram of the E. coli metabolic map involving the metabolites secreted into the extracellular medium during recombinant
fed-batch cultivations. The accumulation (or assimilation) of metabolites was evaluated along four phases: the pre-IPTG induction phase (A), the
post-IPTG induction phase (B), the post-nutrient upshift phase (C) and the glucose limitation phase (D). Graphs represent the time series data relative
to the concentration levels of each metabolite in the metabolic footprint along the fermentation process for the W3110 strain (dark line) and the DrelA
mutant (light gray line) cultures. Bold dashed lines connecting metabolites and biochemical reactions indicate known inhibitory eﬀects on those
reaction-associated enzymes. Grey boxes represented in the metabolic map indicate other metabolites that participate in the metabolism, but were not
detected in these experiments. The dashed square lists the detected metabolites with unknown biosynthetic reactions in E. coli.
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separately. This indicates that changes in the metabolic foot-
print proﬁles were not immediate after IPTG induction, as
observed in the W3110 culture. Only in the late stage of this
fermentation phase those changes in metabolite proﬁles
were detectable. Samples taken immediately after nutrient
downshift (triplicate samples D-1 and D-2) clustered with
samples from phase C, which indicates that these samples have
metabolic proﬁles more similar to samples from phase C than to
those from phase D. This can be due to the fact that, at this
sampling time, cells were still consuming the excess of glucose
accumulated during phase C (see Fig. 1). The other samples
from phase D clustered separately. In this fed-batch culture,
metabolites were not clustered in the same groups as observed
in the W3110 E. coli culture, which reﬂects the existence of
important diﬀerences in the metabolic footprints produced by
the DrelA mutant cells. For example, the 4-hydroxybenzoate
(4hbz) is, at these conditions, clustered with asparagine (asn),
2-isopropylmalate (2paac) and tetradecanoate (ttdca).
Besides the observed diﬀerences between the metabolic
footprints produced at particular growth conditions, diﬀerences
between the set of metabolic variables that better characterized
each phase (i.e. loading proﬁles represented as vectors) were
also explored. Thus, in the next subsections details are exposed
on the key metabolites involved in the alteration of the
metabolic footprints when cells were: (I) induced to express
the heterologous protein; (II) submitted to the nutritional
upshift; and (III) submitted to glucose-limited conditions.
I Impact of IPTG induction on the metabolic footprint.
Fig. 4b shows that the metabolites with the highest positive
loading proﬁles in PC2 (malonate (mlt), itaconate (itcon) and
cis-aconitate (acon-C)) had their levels increased after IPTG
induction in the E. coliW3110 culture. Similarly, these metabolites
also presented high positive loading proﬁles in PC1 of samples
from the DrelAmutant culture (Fig. 5b). In addition, itaconate
and cis-aconitate were clustered using a Pearson correlation
metrics, as represented in the HCA diagrams (Fig. 4a and 5a)
presenting a strong association between their levels along both
fed-batch fermentations.
II Impact of nutrient upshift on the metabolic footprint.
Fig. 4b shows that glycine (gly), succinate (succ), lactate (lac),
citrate (cit), aspartate (asp), 4-hydroxybenzoate (4hbz),
cis-aconitate (acon-C) and itaconate (itcon) are the most
signiﬁcant variables that explain the diﬀerences projected in
PC1 (positive loading proﬁles), which are the diﬀerences
between growth phases B and C of the E. coli W3110 culture.
In fact, as illustrated in Fig. 4a they were grouped in the
same metabolite cluster and represent those that were highly
accumulated after the nutrient upshift. Similarly, positive loading
proﬁles for PC1 and negative for PC2 of the DrelA mutant
culture (Fig. 5b) exposed these metabolites as the most relevant
variables characterizing the samples after nutrient upshift, except
for the hydroxybenzoate (4hbz) and itaconate (itcon).
III Impact of glucose limitation on the metabolic footprint.
In the W3110 E. coli culture (Fig. 4b), negative loading
proﬁles projected in the PC1, corresponding to leucine (leu),
asparagine (asn), 2-isopropylmalate (3c3hmp) and glutamate
(glu), showed the largest diﬀerences after nutrient downshift.
Fig. 3 Principal component analysis (PCA) 2-dimensional projection of
samples from fed-batch cultures of E. coli grown at diﬀerent conditions
based on mass fragment proﬁles of extracellular metabolites analysed by
GC-MS. The Z-score values corresponding to sample replicates for each
metabolite variable were averaged at each sampling point. A total of 36
average proﬁles were considered in the PCA analysis: 18 from samples
taken from the W3110 culture (represented by opened symbols) and the
same amount from the DrelAmutant culture (represented by full symbols).
For each time series, samples represented by squares correspond to samples
withdrawn during the pre-induction phase [A], circles to the post-induction
phase [B], diamonds to the phase after growth upshift [C] and triangles to
the phase after nutrient downshift [D]. Samples are also labelled with letters
corresponding to the cultivation phase (A–D), a number that indicates the
sampling sequence in each cultivation phase and, in some cases the
designation ‘‘relA’’, indicating that it is a sample from the DrelA mutant
culture.
Table 2 Pearson’s correlation coeﬃcients (r) of metabolite proﬁles
from fed-batch cultures of E. coliW3110 and the DrelA mutant strain.
The corresponding p-values were calculated by a Student t-test and
metabolite proﬁles with p-values lower than 0.05 were considered
signiﬁcantly correlated
Metabolite r p-value
2paac 0.3370 0.1714
3c3hmp 0.8020 6.260  105
4hbz 0.5875 1.030  102
acglu a a
acon-C 0.9031 2.870  107
asn 0.7488 3.499  104
asp 0.8199 3.110  105
bnz 0.7222 7.124  104
cbm 0.9568 5.320  1010
cit 0.9115 1.430  107
fum 0.3664 0.1347
glu 0.8814 1.350  106
gly 0.7624 2.347  104
ile a a
itcon 0.8938 5.820  107
lac 0.9049 2.490  107
leu 0.9728 1.380  1011
mal 0.01391 0.9563
mlt 0.8640 3.800  106
ocdca 0.09675 0.7025
ocdcea a a
phe a a
succ 0.7807 1.316  104
ttdca a a
a Undetected in theW3110 culture.See metabolite abbreviations in Fig. 2.
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These metabolites were also clustered by HCA (Fig. 4a). The
loading proﬁles of metabolic footprints from the DrelAmutant
culture (Fig. 5b) depicted glycine (gly), succinate (succ) and
lactate (lac) as adjacent vectors corresponding to metabolites
that were immediately assimilated after glucose limitation.
Discussion
The metabolic footprint analysis is supported on the basis that
cells can secrete metabolites to the extracellular medium during
growth and/or in response to environmental changes.37–39
Furthermore, cells may activate a variety of eﬄux transporters
that work like metabolic relief valves or defensive support to
survive an antagonistic environment.40 In the ﬁrst case, an
increase in extracellular metabolites would be associated
with an increase in the intracellular concentration of those
compounds, while in the second case there would be a gradient
that has to be maintained by the cells to achieve speciﬁc
purposes. In general, the variety and level of the secreted
metabolites reﬂect the metabolic state of the cell and, therefore,
may be considered the closest indicator of the phenotype.4,41–43
Considering this, and the fact that the metabolic impact of
recombinant protein expression in the host cells is still not
well-understood, the metabolic footprints of the recombinant
W3110 and DrelA mutant E. coli cells grown at diﬀerent
experimental conditions were analysed.
The metabolic responses of E. coli cells were evaluated
by measuring some physiological parameters, such as the
cellular growth and acetate formation (Fig. 1 and Table 1).
Results corroborated previous works,14–16 indicating that the
decrease on the cellular growth is the major consequence of the
metabolic burden on the recombinant host cells due to higher
demands of energy and amino acids. The drainage of energy
and biosynthetic precursors associated to the expression of
foreign proteins imposes severe changes in the metabolic
activity of cells and, as a result, reduces the cellular growth.
As shown, upon IPTG induction, the speciﬁc growth rate of
the W3110 and DrelA mutant E. coli strains decreased 50%
and 32%, respectively. The DrelA mutant strain seems to be
less aﬀected, which can be explained by the failure to stimulate
the RelA-dependent stringent response, a stress response
that has been proposed17,44,45 to occur when there is a lack
of intracellular amino acids associated with the additional
requirements for the production of recombinant products.
Ultimately, this stress response may induce a decrease of
cellular growth and protein production. When increasing the
nutrient availability, cells can generate suﬃcient metabolic and
energetic resources for the formation of the heterologous
protein, as well as for growth-associated processes, and as a
result no signiﬁcant physiological diﬀerences between cultures
were observed. However, it was expected that at nutrient
deprived conditions (phase D), the physiological responses
of the two strains would be, at some extent, distinct. Besides
the substrate uptake rates, the estimated physiological para-
meters did not show signiﬁcant diﬀerences between the W3110
and DrelAmutant E. coli cultures. Cellular growth was rapidly
arrested and formation of the heterologous protein decreased
to similar levels, which did not allow us to deduce any
Fig. 4 Analysis of the metabolic footprint proﬁles obtained from the fed-batch aerobic culture of E. coli W3110. (a) Hierarchical clustering
analysis (HCA) distinguished four data classes (vertical clusters), corresponding to extracellular samples taken during each fermentation phase
(including sample replicates), and several metabolite clusters (horizontal clusters) that characterized the metabolic footprint proﬁles during the
recombinant fed-batch cultivation, based on a Pearson correlation metrics. (b) Principal component analysis (PCA) was performed to determine
the most signiﬁcant metabolic changes in the extracellular medium when growth conditions were changed: (I) induction of the heterologous protein
expression; (II) nutritional upshift; and (III) glucose downshift. Biplots depict component scores projected in PCs as coloured dots, which represent
samples clustered by HCA: samples from the ﬁrst cluster (red dots), second cluster (green dots), third cluster (magenta dots) and fourth cluster
(blue dots); and loading proﬁles represented as vectors that indicate metabolites that contributed the most to discriminate between sample clusters
deﬁned by the HCA. Only metabolites with larger vectors were depicted in the biplots, though the whole metabolic footprint data from the W3110
culture were analysed.
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fundamental alterations in the cellular metabolism caused by
the single gene mutation. Therefore, the analysis of extra-
cellular metabolites was invaluable to determine the main
consequences on the physiology of E. coli cells derived from
the relA mutation and the experimental conditions.
As previously reported,37,38 E. coli cells secrete metabolites
according to the adjustments needed in the cellular meta-
bolism to cope with diﬀerent physiological demands. A small,
but considerable number of metabolites characterized the
metabolic footprints produced during the fed-batch processes
and their level ﬂuctuations were inspected to estimate their
relationship with the intracellular metabolic changes. Metabolic
footprints allowed us not only to discriminate between samples
withdrawn at diﬀerent fermentation phases, but also to disclose
some metabolic changes that were not evidenced by the
physiological characterization of the fed-batch cultures.
According to the PCA analysis (Fig. 3), it can be observed
that most samples from the same cultivation phase are close to
each other, except for some samples from phases C and D. On
the other hand, also from PCA results, it can be concluded
that both strains behave similarly during phases A and B, but
quite diﬀerently in the remaining phases, in particular when
comparing PC projections corresponding to samples D-3 and
D-4 with D-3-relA and D-4-relA, respectively.
According to HCA results illustrated in Fig. 4a, samples
from the W3110 E. coli fed-batch culture were discriminated
according to the fermentation phases, which deﬁned clusters
with characteristic metabolic properties. In contrast, samples
from the DrelA mutant E. coli culture (Fig. 5a) were not
equally clustered. When cells were induced to express the
heterologous protein (I) or submitted to glucose-limiting
conditions (III), the metabolic footprints observed before and
immediately after these experimental shifts were equivalent.
In order to justify the diﬀerent behaviour of both strains
regarding the impact of heterologous production and environ-
mental changes in the metabolic proﬁles, it is hypothesised
that the lack of the relA gene allowed cells to face these
stressful conditions during phases B and D in a more
‘‘relaxed’’ way, therefore making the metabolic proﬁles closer
to the following (case of phase A to B) or previous stages
(case of phase C to D). These results are consistent with the higher
production rates of the mutant strain in phase D (Table 1).
Although, as seen in Table 2, most of the metabolites exhibit
similar patterns between both strains and some of the changes
found on the metabolite patterns could be associated with the
intrinsic variability of this kind of experiments, the diﬀerences
found and the accumulation of certain metabolites only
detected in the DrelA mutant culture (e.g. acetyl-L-glutamate
(acglu)) may result from changes on the cellular metabolism
that were not equivalent in the two E. coli cultures.
Analysing the metabolic footprints of both cultures
independently, and regarding IPTG induction of the heterologous
Fig. 5 Analysis of the metabolic footprint proﬁles obtained from the fed-batch aerobic culture of E. coli DrelA mutant strain. (a) Hierarchical
clustering analysis (HCA) distinguished four sample clusters (vertical clusters) and several metabolite clusters (horizontal clusters). Here, sample
clusters did not correspond to each fermentation phases, but illustrate data classes that are characterized by diﬀerent metabolic states deﬁned by
the metabolite footprints detected during the recombinant fed-batch cultivation, based on a Pearson correlation metrics. (b) Principal component
analysis (PCA) was performed to determine the most signiﬁcant metabolic changes in sample clusters. Biplots depict component scores projected in
PCs as dots, which represent samples clustered by HCA: samples clustered in the ﬁrst group (red dots), second cluster (green dots), third cluster
(magenta dots) and fourth cluster (blue dots); and loading proﬁles represented as vectors that indicate metabolites that contributed the most to
discriminate between the sample clusters deﬁned by the HCA. Only metabolites with larger vectors were depicted in the biplots, though the whole
metabolic footprints from the DrelA culture were analysed.
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protein expression in the W3110 E. coli fed-batch culture, a set
of metabolites were depicted as key elements characterizing
the metabolic changes associated with this experimental
transition. Three carboxylic acids (malonate, itaconate and
cis-aconitate) were secreted into the culture broth (Fig. 4b)
suggesting that they were released from the cells to prevent any
inhibitory eﬀects on the activity of isocitrate lyase. As
mentioned before, cis-aconitate and itaconate, as well as
malonic acid,35 are inhibitors of this enzyme, controlling the
activity of the ﬁrst reaction of the glyoxylate shunt that was
reported46 as serving an anaplerotic function in the cell during
heterologous protein production. Since several TCA inter-
mediates are withdrawn from the TCA cycle as amino acid
precursors and need to be replenished, these anaplerotic
reactions are central to balance the intracellular levels of
TCA metabolites, fulﬁlling this way the additional biosynthetic
requirements associated with the formation of the hetero-
logous protein. The DrelA mutant strain response to IPTG
induction was also manifested by the accumulation of the same
enzymatic inhibitors: malonate, cis-aconitate and itaconate
(see Fig. 5b). However, HCA showed that the metabolic
footprints produced immediately after IPTG induction did
not discriminate these samples from the previous fermentation
phase, which suggests that the mutant strain might retard
these regulatory responses after induction of the heterologous
protein production.
Despite the extensive knowledge on basic aspects such as the
changes of growth rates with nutrient concentrations,47–51
information on the eﬀects of the nutritional upshift during
recombinant processes on the metabolic footprint is still
scarce. In general, studies are focused in the secretion of
acetate, not only because it retards growth and inhibits protein
formation, but also because it represents a deviation of carbon
that might otherwise be used to generate energy and precursors
for biosynthetic purposes.52–54 In this study, a glucose feeding
upshift was applied to increase the speciﬁc growth rate during
heterologous protein production and the metabolic footprints
were analysed. Numerous metabolites were immediately
accumulated in the extracellular medium of the W3110 culture
after glucose availability increased, such as glycine (gly),
4-hydroxybenzoate (4hbz), lactate (lac), citrate (cit), cis-aconitate
(acon-C), itaconate (itcon), succinate (succ), fumarate (fum)
and aspartate (asp) (Fig. 4b). If we consider that the increase
in extracellular concentrations is associated with the accumula-
tion of the corresponding intracellular metabolites, which
include TCA intermediaries, amino acids and amino acid
precursors, then two hypotheses can be deduced to explain
this phenomenon. One is the increase in the overall activity of
the metabolic pathways that would lead to a direct increased
concentration of all the intermediates due increased enzyme
activities. The second hypothesis would be related with an
increased inhibitory action that would result in the accumula-
tion of certain metabolites that participate in key reactions
that are subjected to regulation. Although not all TCA cycle
intermediates, amino acids and amino acid precursors have
been measured, there seems to be a clear tendency of increased
concentration of all metabolites, indicating that the ﬁrst
hypothesis might be more plausible. Moreover, acetate was
also accumulated during this fermentation phase resulted from
the glucose overﬂow metabolism. It was reported55 that in the
presence of excess glucose, the carbon ﬂux through glycolysis
exceeds the capacity of the TCA cycle and acetate is
accumulated.
The same set of metabolites, except 4-hydroxybenzoate and
itaconate, were accumulated during the DrelA fermentation
process at these conditions, which indicate that metabolic
adjustments induced by the nutrient upshift resulted in similar
alterations in the metabolic footprints from both strains.
Although some metabolite patterns revealed diﬀerences
between strains (Fig. 2), in general, these were not very
signiﬁcant to distinguish the samples (Fig. 3).
The accumulation of lactate at these conditions was found
intriguing. Since the conversion of pyruvate to lactate in E. coli
is usually exclusively induced at anaerobic conditions,56,57 the
presence of this by-product implies that the internal accumula-
tion of pyruvate due to the metabolism overﬂow overrides any
other mechanism known to control the activity of the lactate
dehydrogenase (LdhA) enzyme under aerobic conditions58 or,
for some reason, local oxygen deﬁciencies during the E. coli
fed-batch process have triggered the ArcAB system and other
genes involved in the mixed acid fermentation pathway.59 The
latest assumption seems improbable, as good mixing con-
ditions and dissolved oxygen values above 30% were maintained
inside the reactor.
Finally, the metabolic responses to nutritional stress
associated with the restriction of glucose feeding during
recombinant E. coli processes were also evaluated. It is
remarkable the amount of metabolites found to be secreted
after glucose downshift. Besides the decreasing levels of meta-
bolites that can serve as carbon sources for E. coli (e.g. acetic
acid), the accumulation of unexpected metabolites, like amino
acids (e.g. leucine (leu), asparagine (asn), glutamate (glu) and
aspartic (asp)) and amino acid derivatives (e.g. 2-isopropyl-
malate (3c3hmp)), indicate that the cells accumulated these
biosynthetic precursors as a consequence of the delayed
protein translation machinery, as estimated by the experimental
AcGFP1 formation rates (Table 1). It is acknowledged that
under nutrient starvation E. coli cells entail complex protective
processes that ultimately manage the cellular metabolism to
sustain cellular maintenance and viability.60–62 Apparently
the RelA-dependent response is involved in these metabolic
readjustments, as the metabolic footprints exhibited by the
wild-type and DrelA mutant E. coli cultures were somehow
divergent (Fig. 3). When comparing the metabolite patterns of
both strains after nutrient downshift, we found that acetate
utilization by E. coli cells has a strong eﬀect on the accumula-
tion of several metabolites, especially in the DrelA mutant
strain (Fig. 2). Metabolites such as phenylalanine (phe), isoleucine
(ile), leucine (leu), acetyl-L-glutamate (acglu) and octadecenoate
(ocdcea) were accumulated in the medium of the DrelAmutant
culture shortly after acetate consumption has started
(data shown in ESI 1w). Under these conditions, acetate is
converted to acetyl coenzyme A (accoA) at the expense of
ATP which, in turn, is mainly catabolised via glyoxylate cycle
that serves as anaplerotic reactions.63 This shift in the utiliza-
tion of carbon sources involves the activation of various
cellular processes, including the synthesis of new catabolic
enzymes and the activation of substrate-speciﬁc transport
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systems. It seems that the metabolic imbalance caused by these
metabolic activities coupled with the additional formation of
the heterologous protein is the basis for the accumulation of
several metabolites, including amino acids, that was more
critical in the DrelA strain (where protein production rates
were also higher in this phase). During glucose starvation the
translational apparatus, as well as cellular growth, are limited
via transcriptional control of several growth-associated genes,
like ribosomal operons. The ppGpp-stringent control has been
related to this cellular response to nutritional deprivation
that redirects the RNA polymerase transcriptional activity
from stable RNA (ribosomal and transfer RNA) synthesis to
stress-related genes, in particular genes that have protective
functions. In the absence of the RelA activity, the ppGpp
accumulation is limited and the translational apparatus stays
unaﬀected. This seems to be the main cause for the only slight
reduction of heterologous protein production rate in the DrelA
mutant. However, while protein production seems to be
unaﬀected by nutrient starvation, bacterial growth was arrested
in this strain, probably by action of responses mediated by
other stress proteins. These facts apparently generated an
imbalance in the mutant strain’s metabolism (probably due
to diﬀerences in amino acid composition between hetero-
logous and average E. coli proteins) that was evidenced by
the accumulation of some amino and fatty acids. For example,
the synthesis of fatty acids is known to be inhibited during
glucose starvation, which did not seem to happen in the
mutant strain. However, since these compounds had not been
used for biomass production, there was an accumulation of
octadecenoate (ocdcea) and tetradecanoate (ttdca) in the
DrelA mutant strain. Moreover, isoleucine (ile), acetyl-L-
glutamate (acglu) and phenylalanine (phe) were also accumulated
at these conditions by the DrelA mutant strain. It seems
evident that the failure to accumulate ppGpp at these condi-
tions allowed a continuous production of the heterologous
protein (although slightly reduced) resulting in an unbalanced
drainage of precursors. Some metabolites were gradually
replenished while others (less required for the production
of AcGFP1) were over-accumulated. The fact that most
metabolic resources were probably redirected to the formation
of AcGFP1 may explain the higher protein synthesis rate and
lower biomass yield observed for the DrelA mutant strain
when compared to the W3110 strain. It is clear that the
relA mutation inﬂuences the natural cellular responses to
nutritional downshifts, which can delay, or even suppress,
E. coli survival and resistance.
Conclusions
Although the characterization of metabolites in E. coli culture
broths has been performed using various detection methods,
such analyses are mostly conﬁned to speciﬁc metabolites and
have not been done in a global scale. For example, the
secretion of acetate during aerobic E. coli fermentations is
regularly measured, because it is considered a major obstacle
to enhanced heterologous protein production. However, the
present work reveals that the complexity of the generated
metabolic footprints at diﬀerent culture conditions is much
higher than what has been admitted. As demonstrated, E. coli
secretes a vast array of metabolites that participate in a wide
range of metabolic pathways. Although the metabolism in
E. coli has been studied more intensively than in any other
bacterium, only recently it has become clear that targeted
studies do not provide an accurate picture of the cellular
metabolism. A typical metabolomic approach is expected
to generate new knowledge from the comprehensive analysis
of the metabolome and the distinctive metabolic patterns
produced at diﬀerent environmental and genetic conditions.
Metabolic footprints resulted from the IPTG-induction of
the heterologous protein expression have shown that there is a
rapid accumulation of unexpected metabolites in the culture
broth. The secretion of the isocitrate lyase inhibitors suggests
that the anaplerotic glyoxylate shunt was activated to replenish
the TCA intermediaries engaged in the additional formation
of the heterologous protein. Moreover, the detection of
compounds unknown to participate in E. coli metabolism
reinforces the importance of unbiased analytical approaches
in research.
When cells are exposed to conditions of nutrient-excess,
the uncoupling of maximum glucose uptake rates and the
TCA ﬂuxes results in a metabolic overﬂow with consequent
accumulation of overﬂow metabolites such as acetate and
lactate. Assuming that the demand for metabolic resources
for cellular growth and heterologous protein production is
exceeded, the secretion of these metabolites can be understood
as a metabolic relief required to avoid adverse eﬀects from the
imbalanced cellular metabolism.4 Also, TCA intermediaries
(e.g. fumarate, succinate, citrate and cis-aconitate) and some
amino acids (e.g. aspartate and glycine) were secreted at these
conditions, probably as a result of the increased activities of
these pathways.
At nutrient-limited conditions (i.e. when glucose feeding
was discontinued), some of these metabolites (e.g. acetate)
were assimilated by the cells as carbon and energy sources.
These metabolic activities, coupled with the formation of the
heterologous protein may have resulted into severe rearrangements
in the cellular metabolism that led to the secretion of amino
acids like: phenylalanine, asparagine, and leucine; and the
acetyl-L-glutamate. Once again, these metabolic imbalances
were more pronounced in the DrelA strain, which fails to
trigger RelA-dependent processes to respond to nutrient
deprivation.
The metabolic ﬂexibility exposed by the alterations in the
metabolic footprints, evidenced that cells entail diverse cellular
mechanisms to sense and rapidly counteract the adverse
environmental conditions. This stringent behaviour was pre-
valent in the W3110 strain, while the DrelA strain showed
some diﬃculties to cope immediately with the metabolic
imbalances caused by the formation of heterologous protein.
It is evident that, although some disadvantages might have
been indicated concerning the metabolic behaviour of the
DrelA strain (e.g. failure to manage metabolic imbalances),
the enhanced production rate of the heterologous protein
represents a major beneﬁt.
Metabolic footprinting, more than most other analytical
strategies, is a rapid and non-invasive analysis, representing
a powerful approach for the characterization of phenotypes
and the distinction of speciﬁc metabolic states due to
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environmental or genetic alterations. Nevertheless, metabolic
footprints are just a shallow representation of the metabolic
state of cells and the full understanding of the underlying
mechanisms controlling these metabolic imbalances caused
by the heterologous protein production, require further
inspection of key metabolites (e.g. metabolites that are
important nodes in the metabolic network) or the combination
with other experimental strategies (e.g. gene expression and
proteomics).
Experimental
Microbial strains
E. coli strains W3110 (F-, LAM-, IN[rrnD-rrnE]1, rph-1) and
the isogenic mutant containing the DrelA251::kan allele
(obtained from M. Cashel, National Institute of Health, USA)
were transformed with the cloned pTRC-HisA-AcGFP1
plasmid encoding the expression of the recombinant AcGFP1
protein. The gfp gene was ampliﬁed from the pAcGFP1
plasmid (Clontech, Takara Bio Company, USA) that encodes
for the green ﬂuorescent protein AcGFP1, a derivative of
AcGFP from Aequorea coerulescens. The PCR product was
then cloned into the pTRC-HisA vector (Invitrogen Corpora-
tion and Applied Biosystems Inc, USA) that contains a
trc promoter for high-level expression of the fusion protein
and an ampicillin resistance gene for propagation and selection
in E. coli.
Growth conditions
Precultures were prepared in 500 mL shaking ﬂasks ﬁlled with
300 mL of minimal medium consisting of 5 g kg1 of glucose,
6 g kg1 of Na2HPO4, 3 g kg
1 of KH2PO4, 0.5 g kg
1 of
NaCl, 1 g kg1 of NH4Cl, 0.015 g kg
1 of CaCl2, 0.12 g kg
1
of MgSO47H2O, 0.34 g kg1 of thiamine, 2 mL kg1 of trace-
element solution (described elsewhere)64 and 2 mL kg1
of vitamins solution (described elsewhere).64 The minimal
medium containing additional 20 mg kg1 of L-isoleucine
and 100 mg kg1 of ampicillin was used to grow the recombinant
wild-type strain, while this same medium with further addition
of 20 mg kg1 L-valine and 25 mg kg1 kanamycin was used to
grow the DrelA mutant strain. Cells were thereafter washed
and transferred to a 5 L fermenter (Biostat MD, Sartorius)
with a working volume of 2 L containing the same minimal
medium, except glucose. The fed-batch operation was started
immediately after inoculation at 37 1C, pH 7 and dissolved
oxygen (DO) above 30%. The feed media used contained
50 g kg1 of glucose, 10 g kg1 of NH4Cl, 4 g kg
1 of
MgSO47H2O and the additional requirements for amino
acids and antibiotics as described before. The induction of
AcGFP1 production was performed with 1.5 mM IPTG
(isopropyl b-D-thiogalactoside) when the microbial culture
reached an OD600 nm of 2.3. Fermentation conditions were
monitored and controlled via a computer control system.
A closed-loop feeding control algorithm was employed to
maintain a constant speciﬁc growth rate (m) in the fed-batch
culture.65 The algorithm is based on a Monod kinetic model
using glucose as the only growth-limiting substrate. The model
combines terms for cell growth (Xm), glucose consumption
(YX/SSf) and the online measurement of culture medium
weight (WR) to control the feeding proﬁle, represented by:
F ¼ XmWR
YX=SSf
The biomass concentration (X) was initially measured
by optical density and estimated at each acquisition time
(every 3 min). The predicted growth yields on glucose (YX/S)
were set to 0.35 and 0.2, when the speciﬁc growth rates were
set to 0.1 and 0.2 h1, respectively. The fed-batch experiments
were at ﬁrst conducted at a setpoint of m = 0.1 h1, corres-
ponding to the pre-induction (A) and the post-induction (B)
phases. Afterwards the setpoint was changed to 0.2 h1, which
was kept during almost 4 h, corresponding to a nutritional
upshift phase (phase C). When the feeding was ceased (glucose
limitation phase or phase D), growth was followed until the
OD600nm dropped.
Sampling and analytical procedures
Samples were collected from the fermentation broth at regular
time intervals (40–50 min) along the four cultivation phases
from each fed-batch fermentation, one with each E. coli strain.
Cell growth was monitored by measuring optical density
(OD600nm) and cell dry weight. In order to determine cell dry
weight, 10 mL of broth were centrifuged at 10 000 g for 20 min
at 4 1C, washed twice with deionised water and dried at 105 1C
to constant weight. The expression level of AcGFP1 was
determined by ﬂuorescence measurements at a Jasco FP-6200
spectroﬂuorometer with excitation and emission wavelengths
of 475 and 505 nm, respectively, a bandwidth of 10 nm and a
high sensitivity response in 0.1 s. His-Tag puriﬁcation of the
AcGFP1 was performed with HiTrap columns (GE Healthcare
Bio-Sciences AB, Sweden) and the concentration was deter-
mined by the Bradford method using BSA as standard. For
further analysis, culture samples were centrifuged (15 min,
3000 rpm, 4 1C) and the resulting supernatants were immediately
ﬁltered and collected. Afterwards the samples were stored at
20 1C for subsequent analysis and lyophilisation. Glucose
and acetate were analysed by HPLC with a refractive index
detector (Jasco, Canada) and a Chrompack organic acids
column (Varian, USA) at 35 1C. The mobile phase consisted
in a 0.01 N solution of H2SO4 at a ﬂow rate of 0.6 mL min
1.
Derivatization and GC-MS analysis
For the GC-MS analysis, only the supernatants collected from
samples for which biomass concentration was above 0.6 g kg1
were used to determine metabolic footprints (see Fig. 1b). One
millilitre of the supernatants was lyophilized in triplicate. The
lyophilized samples were then derivatized using the methyl
chloroformate (MCF) method66 and analyzed with a GC-MS
system-GC7890 coupled to an MSD5975—(Agilent Techno-
logies, Inc., Santa Clara, CA, USA) equipped with a ZB-1701
GC capillary column, 30 m  250 mm id  0.15 mm
(ﬁlm thickness) with 5 m guard column (Phenomenex, Inc.,
Torrance, CA, USA), at a constant ﬂow rate of 1.0 mL min1
of helium. Samples (1 mL) were injected onto the column under
a pulsed splitless mode (1.8 bars until 1 min, 20 mL min1 split
ﬂow after 1.01 min) and the detector was set with a scan
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interval of 1.47 s and m/z range of 38–650. The oven tempera-
ture was initially held at 45 1C for 2 min. Thereafter, the
temperature was raised with a gradient of 9 1C min1 until
180 1C and held at this value for 5 min. The temperature was
raised again at a gradient of 40 1C min1 in three steps: until
220 1C (held for 5 min), 240 1C (held for 11.5 min) and ﬁnally
280 1C (held for 2 min). The temperature of the inlet was
290 1C, the interface temperature 250 1C, and the quadrupole
temperature 200 1C.
Data processing and statistical analysis
Time series data consisted in a sequence of samples lyophilized,
derivatized and analyzed in triplicate (in most cases), for the
four cultivation phases for each fed-batch culture. Each time
series consisted in 18 sampling points, where the ﬁrst ﬁve
sampling points (T0 to T4) corresponded to samples collected
during phase A (prior to IPTG induction), the next ﬁve
(T5 to T9) to samples from phase B (after IPTG induction),
other four (T10 to T13) to samples from the growth upshift
phase (C) and, the last four (T14 to T17) from the nutrient
downshift phase (D). In the end, about 50–52 samples
(including replicates) were analysed by GC-MS to characterize
the metabolic footprints from each E. coli culture.
The mass fragmentation spectrum was analysed using the
Automated Mass Spectral Deconvolution and Identiﬁcation
System (AMDIS)67 to identify the compounds through matching
with a library constructed by using analytical chemical
standards. The peak intensity values from the AMDIS analysis
were corrected for the recovery of the internal standard
(D-4-alanine), i.e. divided by the intensity peak of the internal
standard in each sample, and normalized with the corresponding
biomass concentration, i.e. further divided by the biomass
concentration measured in each sampling point. Data are
provided in ESI 2.w These peak intensity values were thereafter
transformed into Z-scores, where each metabolite K has mean
peak intensity values equal to zero and standard deviation of
one. Z-score values were calculated by subtracting the average
peak intensity values for a metabolite K among all the n
samples (including replicates) from the peak intensity value
(IK,i) for that metabolite in sample i, and dividing that result
by the standard deviation of all measured peak intensities
corresponding to that metabolite K, according to:
Z  scorek;i ¼ ðIk;i mean Ik;1...k;nÞ
SDk;1...k;n
Further data processing and statistical analysis were performed
with MATLAB (version 2009b, The Mathworks, Inc) and Multi-
Experiment Viewer (MeV).68 A ﬁrst principal component analysis
(PCA) was performed using the princompMATLAB function on
a matrix of the Z-score values of each measured metabolite
(with averages for sample replicates) that included samples from
all cultivation phases and from both E. coli cultures, i.e. a total of
36 average proﬁles were used in this analysis.
The degree of association between the metabolite proﬁles
produced by the W3110 and DrelA E. coli cultures was deter-
mined using Pearson’s correlation coeﬃcients (r) estimated by
the MATLAB corr function. P-values associated with each
Pearson correlation coeﬃcient were calculated using a Student
t distribution to test the null hypothesis (H0) of no signiﬁcant
correlation between the metabolite proﬁles from the two
cultures, against the alternative hypothesis (H1) that establishes
a signiﬁcant correlation between the proﬁles. The p-value for
Pearson’s correlation coeﬃcient is based on the test statistic, t,
with n  2 degrees of freedom:
t ¼ r
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n 2p
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 r2
p
To further examine metabolic changes following alterations in
growth conditions, two clustering analyses were performed on
GC-MS data acquired from independent fed-batch cultures:
hierarchical clustering analysis (HCA) and PCA. Samples used
were not averaged among replicates in these clustering analyses.
Hierarchical clustering analysis (HCA) was used to cluster
samples and metabolites based on the Pearson correlation metrics
(MeV software) and was performed on matrices (corresponding
to each E. coli cultures) of Z-score values determined for each
detected metabolite in samples (including replicates) collected
from four diﬀerent cultivation phases (A to D). Two-dimensional
score plots and loading proﬁles of the principal components (PC)
were used to visualize the relative contribution of individual
metabolites to discriminate between sample clusters previously
determined by HCA. In other words, each biplot was constructed
based on component scores and loading proﬁles estimated by the
princomp MATLAB function with samples from two clusters
deﬁned previously by HCA, in order to identify the metabolic
shifts that best characterize the discrimination of the two sample
clusters. Since samples were clustered in a sequential time course,
samples included in the ﬁrst cluster were compared with samples
from the second cluster, samples from the second cluster with
samples from the third cluster, and so on. Three biplots were used
to compare the four sample clusters determined in each HCA,
which were associated with speciﬁc growth shifts performed
during the fed-batch cultures: (I) IPTG induction of the hetero-
logous protein expression, (II) growth upshift and (III) glucose
downshift. Although these shifts between sample clusters and
cultivation phases were in agreement only for the W3310 culture,
it was assumed that metabolic shifts were fundamentally caused
by these growth alterations. Metabolic shifts are characterized in
each biplot where sample scores are represented by colored dots
according to the cluster enclosing that sample and loading proﬁles
are represented as vectors that indicate which metabolites
presented the highest alterations among samples (larger vectors).
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